Shanghai Fosun Pharmaceutical Group Co Ltd banner

Shanghai Fosun Pharmaceutical Group Co Ltd
SWB:08HH

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SWB:08HH
Watchlist
Price: 1.8615 EUR -0.96% Market Closed
Market Cap: €7.7B

Wall St Price Targets

08HH Price Targets Summary
Shanghai Fosun Pharmaceutical Group Co Ltd

Wall Street analysts forecast 08HH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 08HH is 2.661 EUR with a low forecast of 1.9795 EUR and a high forecast of 3.074 EUR.

Lowest Forecast
Price Target
1.9795 EUR
6% Upside
Average Forecast
Price Target
2.661 EUR
43% Upside
Highest Forecast
Price Target
3.074 EUR
65% Upside
Shanghai Fosun Pharmaceutical Group Co Ltd Competitors:
Price Targets

Revenue
Forecast

14% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
14% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

15% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
15% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
14% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 08HH's stock price target?
Price Target
2.661 EUR

According to Wall Street analysts, the average 1-year price target for 08HH is 2.661 EUR with a low forecast of 1.9795 EUR and a high forecast of 3.074 EUR.

What is the Revenue forecast for Shanghai Fosun Pharmaceutical Group Co Ltd?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Shanghai Fosun Pharmaceutical Group Co Ltd?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 1%.

What is the Operating Income forecast for Shanghai Fosun Pharmaceutical Group Co Ltd?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Shanghai Fosun Pharmaceutical Group Co Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Shanghai Fosun Pharmaceutical Group Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett